Nuo Therapeutics Inc (AURX)
0.75
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nuo Therapeutics Total Assets (Quarterly): 1.243M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.243M |
December 31, 2023 | 1.878M |
September 30, 2023 | 1.600M |
June 30, 2023 | 1.385M |
March 31, 2023 | 2.221M |
December 31, 2022 | 3.047M |
September 30, 2022 | 3.865M |
June 30, 2022 | 4.323M |
March 31, 2022 | 1.058M |
December 31, 2021 | 1.466M |
September 30, 2021 | 0.1499M |
December 31, 2020 | 0.1531M |
December 31, 2019 | 0.1573M |
September 30, 2019 | 0.0385M |
June 30, 2019 | 0.1543M |
March 31, 2019 | 0.4614M |
December 31, 2018 | 0.9755M |
September 30, 2018 | 0.7598M |
June 30, 2018 | 0.8233M |
March 31, 2018 | 0.9727M |
December 31, 2017 | 1.424M |
September 30, 2017 | 10.21M |
June 30, 2017 | 8.840M |
March 31, 2017 | 12.42M |
December 31, 2016 | 14.06M |
Date | Value |
---|---|
September 30, 2016 | 16.75M |
June 30, 2016 | 19.60M |
March 31, 2016 | 6.904M |
December 31, 2015 | 7.074M |
September 30, 2015 | 19.15M |
June 30, 2015 | 46.47M |
March 31, 2015 | 52.74M |
December 31, 2014 | 56.22M |
September 30, 2014 | 60.26M |
June 30, 2014 | 65.33M |
March 31, 2014 | 50.24M |
December 31, 2013 | 46.25M |
September 30, 2013 | 46.89M |
June 30, 2013 | 46.57M |
March 31, 2013 | 50.78M |
December 31, 2012 | 44.33M |
September 30, 2012 | 47.54M |
June 30, 2012 | 50.40M |
March 31, 2012 | 49.35M |
December 31, 2011 | 10.08M |
September 30, 2011 | 9.047M |
June 30, 2011 | 7.964M |
March 31, 2011 | 8.857M |
December 31, 2010 | 8.900M |
September 30, 2010 | 9.090M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0385M
Minimum
Sep 2019
4.323M
Maximum
Jun 2022
1.516M
Average
1.385M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
AIM ImmunoTech Inc | 19.38M |
Perspective Therapeutics Inc | 278.29M |
Protalix BioTherapeutics Inc | 89.82M |
Electromed Inc | 48.90M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.9094M |
Shareholders Equity (Quarterly) | 0.3334M |
Current Ratio | 1.289 |